(Q30908064)

27 June 2017

1 reference

title

Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics (English)

1 reference

27 June 2017

0 references

1 reference

Jack C de la Torre

1

1 reference

27 June 2017

publication date

1 March 2004

1 reference

27 June 2017

1 reference

27 June 2017

volume

3

1 reference

27 June 2017

issue

3

1 reference

27 June 2017

page(s)

184-190

1 reference

Amyloid plaque core protein in Alzheimer disease and Down syndrome

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Presenilin-1-associated abnormalities in regional cerebral perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

The natural history of mental disorder in old age.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

The molecular pathology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Alzheimer's disease: a re-examination of the amyloid hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

The amyloid hypothesis: let sleeping dogmas lie?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Alzheimer disease as a vascular disorder: nosological evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Age, neurofibrillary changes, A beta-amyloid and the onset of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Frequency of stages of Alzheimer-related lesions in different age categories

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Alzheimer neuropathologic alterations in aged cognitively normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Neuronal activity and early neurofibrillary tangles in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

The role of cerebral ischemia in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Specific spatial learning deficits become severe with age in beta -amyloid precursor protein transgenic mice that harbor diffuse beta -amyloid deposits but do not form plaques

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Short-term beta-amyloid vaccinations do not improve cognitive performance in cognitively impaired APP + PS1 mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

The search for an amyloid solution.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Predicting the failure of amyloid-beta vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

1 reference

7 January 2021

The production of amyloid beta peptide is a critical requirement for the viability of central neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Abeta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Vascular risk factors for Alzheimer's disease: an epidemiologic perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Hypertension and related factors in the etiology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Clinical determinants of poststroke dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Small vessel disease and Alzheimer's dementia: pathological considerations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Comparison of magnetic resonance imaging in Alzheimer's disease, vascular dementia and normal aging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Relevance of white matter changes to pre- and poststroke dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Silent brain infarcts and the risk of dementia and cognitive decline.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Effects of subcortical cerebral infarction on cortical glucose metabolism and cognitive function

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Prevalence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Atrial fibrillation and cognitive function: case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Standardized incidence ratios of stroke: a worldwide review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Women, myocardial infarction, and dementia in the very old.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Atrial fibrillation and dementia in a population-based study. The Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Central nervous system complications in coronary artery bypass graft surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Determinants of cognitive change after coronary artery bypass surgery: a multifactorial problem

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Pulse pressure and risk of Alzheimer disease in persons aged 75 years and older: a community-based, longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Impact of carotid endarterectomy upon cognitive functioning. A systematic review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Hippocampal nitric oxide upregulation precedes memory loss and A beta 1-40 accumulation after chronic brain hypoperfusion in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Cognitive disorders in patients with occlusive disease of the carotid artery: a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Neuropsychometric changes in patients after carotid endarterectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Critical threshold cerebral hypoperfusion causes Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Hemodynamic consequences of deformed microvessels in the brain in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Pharmacotherapy for Alzheimer's disease: 2002.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

The lowdown on Ginkgo biloba.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Prevention of brain aging and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Brain blood flow restoration 'rescues' chronically damaged rat CA1 neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Cerebral hypoperfusion yields capillary damage in the hippocampal CA1 area that correlates with spatial memory impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Cerebrovascular hypoperfusion: a risk factor for Alzheimer's disease? Animal model and postmortem human studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Thickening of the basement membrane of cortical capillaries in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Brain microvascular changes in Alzheimer's disease and other dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Transplantation of endothelial progenitor cells for therapeutic neovascularization.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Isolation of putative progenitor endothelial cells for angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Vascular progenitors: from biology to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Perfusion abnormalities in prodromal AD.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Hippocampal perfusion in mild Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Hippocampal formation glucose metabolism and volume losses in MCI and AD.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900683-0

7 January 2021

10.1016/S1474-4422(04)00683-0

Identifiers

DOI

1 reference

27 June 2017

1 reference